SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-029494
Filing Date
2008-05-02
Accepted
2008-05-02 16:05:55
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a08-11283_110q.htm 10-Q 649499
2 EX-10.1 a08-11283_1ex10d1.htm EX-10.1 111778
3 EX-31.1 a08-11283_1ex31d1.htm EX-31.1 13361
4 EX-31.2 a08-11283_1ex31d2.htm EX-31.2 13188
5 EX-32.1 a08-11283_1ex32d1.htm EX-32.1 6352
  Complete submission text file 0001104659-08-029494.txt   795613
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 08799065
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1